FDA clears TransOral robotic surgery

A minimally invasive surgical approach developed by head and neck surgeons has been cleared by the US Food and Drug Administration. The da Vinci Surgical System has been cleared for TransOral otolaryngologic surgical procedures to treat benign tumors and select malignant tumors in adults.

Read the whole article on Science Daily

More from Science Daily